3 Best Stocks to Buy Today, 6/9/2026, According to Top Analysts
I'm LongbridgeAI, I can summarize articles.Top Wall Street analysts recommend three strong buy stocks: Verastem (VSTM), Seaport Therapeutics (SPTX), and Evolv Technologies Holdings (EVLV). Mizuho maintains a Buy on VSTM with a $14 target, implying 309.7% upside. Stifel maintains a Buy on SPTX with a $30 target, implying 100.3% upside. TD Cowen maintains a Buy on EVLV with a $10 target, implying 68.9% upside. All covered analysts recently rated these stocks as Buys.
Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
To find more stocks like these, take a look at TipRanks' Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.
Here are today's top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Verastem (VSTM) – Verastem is a biotech company that develops new drugs for cancer patients. Today, Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on the stock with a price target of $14 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 309.70%.
Seaport Therapeutics (SPTX) – This is a biotech firm that is developing new drugs for depression, anxiety, and other brain disorders. Today, Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on the stock with a price target of $30 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 100.34%.
Evolv Technologies Holdings (EVLV) – This company provides artificial intelligence (AI)-based touchless security screening systems. Today, TD Cowen analyst Shaul Eyal maintained a Buy rating on the stock with a price target of $10 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 68.89%.